190 related articles for article (PubMed ID: 29263243)
1. A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells.
Jiang Y; Yau MK; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
J Pharmacol Exp Ther; 2018 Feb; 364(2):246-257. PubMed ID: 29263243
[TBL] [Abstract][Full Text] [Related]
2. Pathway-selective antagonism of proteinase activated receptor 2.
Suen JY; Cotterell A; Lohman RJ; Lim J; Han A; Yau MK; Liu L; Cooper MA; Vesey DA; Fairlie DP
Br J Pharmacol; 2014 Sep; 171(17):4112-24. PubMed ID: 24821440
[TBL] [Abstract][Full Text] [Related]
3. Biased Signaling by Agonists of Protease Activated Receptor 2.
Jiang Y; Yau MK; Kok WM; Lim J; Wu KC; Liu L; Hill TA; Suen JY; Fairlie DP
ACS Chem Biol; 2017 May; 12(5):1217-1226. PubMed ID: 28169521
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of protease-activated receptor 2 protects against experimental colitis.
Lohman RJ; Cotterell AJ; Suen J; Liu L; Do AT; Vesey DA; Fairlie DP
J Pharmacol Exp Ther; 2012 Feb; 340(2):256-65. PubMed ID: 22028393
[TBL] [Abstract][Full Text] [Related]
5. Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110).
Suen JY; Barry GD; Lohman RJ; Halili MA; Cotterell AJ; Le GT; Fairlie DP
Br J Pharmacol; 2012 Mar; 165(5):1413-23. PubMed ID: 21806599
[TBL] [Abstract][Full Text] [Related]
6. Novel agonists and antagonists for human protease activated receptor 2.
Barry GD; Suen JY; Le GT; Cotterell A; Reid RC; Fairlie DP
J Med Chem; 2010 Oct; 53(20):7428-40. PubMed ID: 20873792
[TBL] [Abstract][Full Text] [Related]
7. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
8. Mapping transmembrane residues of proteinase activated receptor 2 (PAR
Suen JY; Adams MN; Lim J; Madala PK; Xu W; Cotterell AJ; He Y; Yau MK; Hooper JD; Fairlie DP
Pharmacol Res; 2017 Mar; 117():328-342. PubMed ID: 27993717
[TBL] [Abstract][Full Text] [Related]
9. PAR1 and PAR2 couple to overlapping and distinct sets of G proteins and linked signaling pathways to differentially regulate cell physiology.
McCoy KL; Traynelis SF; Hepler JR
Mol Pharmacol; 2010 Jun; 77(6):1005-15. PubMed ID: 20215560
[TBL] [Abstract][Full Text] [Related]
10. Proteinase-activated receptor 2 (PAR2) decreases apoptosis in colonic epithelial cells.
Iablokov V; Hirota CL; Peplowski MA; Ramachandran R; Mihara K; Hollenberg MD; MacNaughton WK
J Biol Chem; 2014 Dec; 289(49):34366-77. PubMed ID: 25331954
[TBL] [Abstract][Full Text] [Related]
11. Binding of a highly potent protease-activated receptor-2 (PAR2) activating peptide, [3H]2-furoyl-LIGRL-NH2, to human PAR2.
Kanke T; Ishiwata H; Kabeya M; Saka M; Doi T; Hattori Y; Kawabata A; Plevin R
Br J Pharmacol; 2005 May; 145(2):255-63. PubMed ID: 15765104
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase D and Gβγ mediate sustained nociceptive signaling by biased agonists of protease-activated receptor-2.
Zhao P; Pattison LA; Jensen DD; Jimenez-Vargas NN; Latorre R; Lieu T; Jaramillo JO; Lopez-Lopez C; Poole DP; Vanner SJ; Schmidt BL; Bunnett NW
J Biol Chem; 2019 Jul; 294(27):10649-10662. PubMed ID: 31142616
[TBL] [Abstract][Full Text] [Related]
13. Thromboxane A2 receptor-mediated release of matrix metalloproteinase-1 (MMP-1) induces expression of monocyte chemoattractant protein-1 (MCP-1) by activation of protease-activated receptor 2 (PAR2) in A549 human lung adenocarcinoma cells.
Li X; Tai HH
Mol Carcinog; 2014 Aug; 53(8):659-66. PubMed ID: 23475608
[TBL] [Abstract][Full Text] [Related]
14. Benzylamide antagonists of protease activated receptor 2 with anti-inflammatory activity.
Yau MK; Liu L; Lim J; Lohman RJ; Cotterell AJ; Suen JY; Vesey DA; Reid RC; Fairlie DP
Bioorg Med Chem Lett; 2016 Feb; 26(3):986-991. PubMed ID: 26725028
[TBL] [Abstract][Full Text] [Related]
15. Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015).
Yau MK; Lim J; Liu L; Fairlie DP
Expert Opin Ther Pat; 2016; 26(4):471-83. PubMed ID: 26936077
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase-2: A key regulator in coagulation proteases mediated human breast cancer progression through autocrine signaling.
Das K; Prasad R; Ansari SA; Roy A; Mukherjee A; Sen P
Biomed Pharmacother; 2018 Sep; 105():395-406. PubMed ID: 29870887
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells.
Gratio V; Beaufort N; Seiz L; Maier J; Virca GD; Debela M; Grebenchtchikov N; Magdolen V; Darmoul D
Am J Pathol; 2010 Mar; 176(3):1452-61. PubMed ID: 20056842
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E(2) inhibits proteinase-activated receptor 2-signal transduction through regulation of receptor internalization.
Komatsu H; Enjouji S; Ito A; Ohama T; Sato K
J Vet Med Sci; 2013; 75(3):255-61. PubMed ID: 23064451
[TBL] [Abstract][Full Text] [Related]
19. PAR2-induced inflammatory responses in human kidney tubular epithelial cells.
Vesey DA; Suen JY; Seow V; Lohman RJ; Liu L; Gobe GC; Johnson DW; Fairlie DP
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F737-50. PubMed ID: 23283995
[TBL] [Abstract][Full Text] [Related]
20. PAR2 induces ovarian cancer cell motility by merging three signalling pathways to transactivate EGFR.
Jiang Y; Lim J; Wu KC; Xu W; Suen JY; Fairlie DP
Br J Pharmacol; 2021 Feb; 178(4):913-932. PubMed ID: 33226635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
